CD8A and neoplasm: Mice were observed for tumor development for 250 days after adoptive transfer and by the end of this observation period, all mice that received donor CD8+ T cells from MBTA treated mice developed tumor, whereas 80% of mice that received donor CD4+ T cells from MBTA treated mice were protected against the tumor development (Figure 5B).